BR112013009679B1 - uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação - Google Patents

uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação Download PDF

Info

Publication number
BR112013009679B1
BR112013009679B1 BR112013009679-9A BR112013009679A BR112013009679B1 BR 112013009679 B1 BR112013009679 B1 BR 112013009679B1 BR 112013009679 A BR112013009679 A BR 112013009679A BR 112013009679 B1 BR112013009679 B1 BR 112013009679B1
Authority
BR
Brazil
Prior art keywords
peptide
fsy
fty
sequence
food
Prior art date
Application number
BR112013009679-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112013009679A2 (pt
Inventor
Jaran Rauo
Original Assignee
Marealis As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marealis As filed Critical Marealis As
Publication of BR112013009679A2 publication Critical patent/BR112013009679A2/pt
Publication of BR112013009679B1 publication Critical patent/BR112013009679B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013009679-9A 2010-10-26 2011-07-13 uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação BR112013009679B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide
GB1018125.3 2010-10-26
PCT/GB2011/051314 WO2012056205A1 (en) 2010-10-26 2011-07-13 Peptide

Publications (2)

Publication Number Publication Date
BR112013009679A2 BR112013009679A2 (pt) 2016-07-12
BR112013009679B1 true BR112013009679B1 (pt) 2020-12-01

Family

ID=43365585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009679-9A BR112013009679B1 (pt) 2010-10-26 2011-07-13 uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação

Country Status (11)

Country Link
US (2) US9044511B2 (https=)
EP (1) EP2632937B8 (https=)
JP (1) JP5879356B2 (https=)
CN (1) CN103249741B (https=)
AU (1) AU2011322287B2 (https=)
BR (1) BR112013009679B1 (https=)
CA (1) CA2856153C (https=)
DK (1) DK2632937T3 (https=)
GB (1) GB201018125D0 (https=)
RU (1) RU2572623C2 (https=)
WO (1) WO2012056205A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337711A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Pro‑Hyp及应用和药物组合物
CN107325153A (zh) * 2017-07-26 2017-11-07 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Hyp‑Pro及应用和药物组合物
JPWO2021059840A1 (ja) * 2019-09-27 2021-10-07 太陽化学株式会社 アンジオテンシン変換酵素阻害剤
TWI890506B (zh) * 2024-06-27 2025-07-11 開曼群島商味丹國際（控股）有限公司 具有抑制ace活性之胜肽及其組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US5545719A (en) 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
RU2084458C1 (ru) * 1993-05-27 1997-07-20 Институт высокомолекулярных соединений РАН Декапептид, обладающий противоопухолевой активностью
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
AU2003253301A1 (en) 2003-07-31 2004-07-14 Franco Felici Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
HUP0600814A3 (en) * 2006-10-27 2009-08-28 Biostatin Gyogyszerkutato Fejl Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
CN101092450A (zh) * 2007-01-10 2007-12-26 中国人民解放军第三军医大学第一附属医院 与人mhc－ⅰ类分子结合的肝素酶多肽表位
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
FR2943346B1 (fr) 2009-03-19 2011-05-06 Univ Paris Curie Peptides modulant l'activite de l'igf-1 et leurs applications
GB201008462D0 (en) 2010-05-20 2010-07-07 Marealis As Process

Also Published As

Publication number Publication date
CN103249741A (zh) 2013-08-14
US20130281358A1 (en) 2013-10-24
CN103249741B (zh) 2015-12-02
JP5879356B2 (ja) 2016-03-08
BR112013009679A2 (pt) 2016-07-12
WO2012056205A1 (en) 2012-05-03
RU2572623C2 (ru) 2016-01-20
JP2014500245A (ja) 2014-01-09
EP2632937A1 (en) 2013-09-04
CA2856153C (en) 2019-04-16
RU2013124991A (ru) 2014-12-10
AU2011322287A1 (en) 2013-05-02
EP2632937B1 (en) 2016-03-16
GB201018125D0 (en) 2010-12-08
AU2011322287B2 (en) 2015-06-25
CA2856153A1 (en) 2012-05-03
EP2632937B8 (en) 2016-06-22
US9044511B2 (en) 2015-06-02
DK2632937T3 (en) 2016-05-30
US20150315236A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
Xue et al. Activity and bioavailability of food protein‐derived angiotensin‐I‐converting enzyme–inhibitory peptides
Muguruma et al. Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: Evaluation of its antihypertensive effects in vivo
Ko et al. Angiotensin I-converting enzyme inhibitory peptides from an enzymatic hydrolysate of flounder fish (Paralichthys olivaceus) muscle as a potent anti-hypertensive agent
Manikkam et al. A review of potential marine-derived hypotensive and anti-obesity peptides
Saleh et al. Recent research in antihypertensive activity of food protein-derived hydrolyzates and peptides
KR101533308B1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
WO2010125192A1 (en) Use of a casein-derived peptide and compositions thereof as antihypertensive
KR102265501B1 (ko) 다중구리 산화효소 펩타이드를 포함하는 구리대사 관련 신경계 질환의 예방 또는 치료용 조성물
US9044511B2 (en) Peptide
Lin et al. Role of the ACE2‑Ang‑(1‑7)‑Mas axis in blood pressure regulation and its potential as an antihypertensive in functional foods
ES2328835T3 (es) Hidrolizado de proteinas con efecto antidiabetico.
JP2004099447A (ja) コレステロール低減化ペプチド
KR101404850B1 (ko) 클로렐라 유래 항고혈압 활성을 갖는 펩티드
WO2014030977A1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
KR20120021590A (ko) 틸라피아 비늘의 효소적 가수분해물을 유효성분으로 포함하는 고혈압의 예방 또는 치료용 약학적 조성물
Babji et al. Anti-oxidative, Anti-inflammatory, Anti-diabetic and Anti-ACE hydrolysates derived from fish protein: A review of multifunctional peptides
BRPI0809319A2 (pt) Agente para suprimir espessamento de parede de coração, agente profilático para hipertrofia cardíaca, agente profilático para insuficiência cardíaca, e, alimento funcional
KR20110087416A (ko) 꽁치 가수분해물을 포함하는 고혈압 예방 또는 개선용 조성물
KR20250137070A (ko) 신규한 아밀린 호르몬 변이 펩타이드 및 이의 용도
KR20250017027A (ko) Ccl8 결합 펩타이드를 포함하는 vegf 유도-혈관신생 억제용 조성물.
EP3170507B1 (en) Antihypertensive peptides from olive oil
JP5430803B2 (ja) ペプチドおよびアンジオテンシン変換酵素阻害剤
KR20080027429A (ko) 숙취해소용 펩타이드
KR20130142316A (ko) 조기 비늘의 효소적 가수분해물을 유효성분으로 포함하는 고혈압의 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: MAREALIS AS (NO)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/07/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2840 DE 10-06-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.